Maximizing Bioavailability and Commercial Success with Softgels
About This Webcast
This session will explore the critical role of bioavailability in a drug's success and how softgel technology can be a strategic solution for commercial longevity. Dr. Peter Surman, Dr. Brett Wagner, and Chris Cuthbertson will look at how a molecule's market potential is often limited not by its efficacy but by its poor delivery and absorption. They will explain the scientific challenges of bioavailability, such as poor solubility and stability, and how these issues can lead to increased R&D costs, clinical trial failures, and lost market share. Using case studies they will demonstrate how strategic formulation can overcome significant challenges, such as a drug's food effect or very low bioavailability. Finally, they will share how early-stage molecule characterization and a partnership with a company like Douglas can be crucial for navigating the complex pathway from candidate selection to market, ultimately helping clients accelerate their drug's journey to patients and achieve market leadership.
Speakers
Dr. Peter Surman
Chief Scientific Officer , Douglas CDMO
Dr. Peter Surmanis is responsible for New Product Development (NPD), Clinical Affairs, and NPD Regulatory Affairs. He leads a team of scientists in the development and global market launch of pharmaceutical products. His work has focused on finding new uses for established medicines, andhe has been involved in the development and launch of many generic and repurposed medicines including R-107, a proprietary ketamine extended-release tablet for treating treatment-resistant depression.
Dr. Brett Wagner
R&D Evaluation Manager , Douglas CDMO
Dr. Brett Wagner specializes in identifying innovative opportunities for in-licensing. She has a keen focus on drug repurposing and connections with universities.
Chris Cuthbertson
Program Manager for Pharmaceutical Development , Douglas CDMO
With over three decades of experience, Chris Cuthbertson has progressed from roles in quality control, R&D, and project management before advancing to his current leadership role in program management.
Tim Wright
Editor-in-Chief , Contract Pharma
Tim Wright is the editor of Contract Pharma magazine, which is a trade publication serving thousands of pharma and biopharma outsourcing professionals. He has been editor at Rodman Media since 2006. Prior to his position at Contract Pharma, he was an editor at Coatings World and Nonwovens Industry publications. Tim has a B.A. from Montclair State University in New Jersey where he studied English literature and journalism.